[1] Fiorillo M, Sanchez-Alvarez R, Sotgia F, et al. The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: implicating TIGAR in somatic resistance to endocrine therapy [J]. Aging (Albany NY), 2018, 10(12):4000-4023.
[2] Huang D, Lu W, Zou S, et al. Rho GDP-dissociation inhibitorα is a potential prognostic biomarker and controls telomere regulation in colorectal cancer [J]. Cancer Sci, 2017, 108(7):1293-1302.
[3] Cho HJ, Kim JT, Lee SJ, et al. Protein phosphatase 1B dephosphorylates Rho guanine nucleotide dissociation inhibitor 1 and suppresses cancer cell migration and invasion [J]. Cancer Lett, 2018, 417(1):141-151.
[4] Xie F, Shao S, Aziz AUR, et al. Role of Rho-specific guanine nucleotide dissociation inhibitorα regulation in cell migration [J]. Acta Histochem, 2017, 119(3):183-189.
[5] Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems [J]. Science, 2013, 339(6121):819-823.
[6] Bannikov AV, Lavrov AV. CRISPR/Cas9, the king of genome editing tools [J]. Mol Biol (Mosk), 2017, 51(4):582-594.
[7] Ma Y, Zhang L, Huang X. Genome modification by CRISPR/Cas9 [J]. FEBS J, 2014, 281(23):5186-5193.
[8] Tran NT, Sommermann T, Graf R, et al. Efficient CRISPR/Cas9-mediated gene knockin in mouse hematopoietic stem and progenitor cells [J]. Cell Rep, 2019, 28(13):3510-3522.
[9] Lei YT, Liu L, Zuo YZh, et al. Effect of dihydromyricetin on the proliferation and migration ability in choriocarcinoma JEG-3 and JAR cells [J]. Acta Anatomica Sinica, 2019, 50(3): 317-323. (in Chinese)
雷赟涛,刘镭,左彦珍,等. 二氢杨梅素对绒毛膜癌细胞增殖和迁移能力的影响 [J]. 解剖学报,2019, 50(3): 317-323.
[10] Wang XJ,Yang YJ,Tian HN,et al. Effects of annexin A5 low expression on migration and invasion of HeLa cells [J]. Acta Anatomica Sinica, 2019, 47(4):487-492. (in Chinese)
王小杰,杨艳杰,田焕娜,等. 膜联蛋白A5低表达对人宫颈癌HeLa细胞迁移和侵袭的影响 [J]. 解剖学报,2016, 47(4):487-492.
[11] Tanaka S, Ishihara N, Suzuki S, et al. Fatty acid desaturase 2 is up-regulated by the treatment with statin through geranylgeranyl pyrophosphate-dependent Rho kinase pathway in HepG2 cells [J]. Sci Rep, 2019, 9(1):10009-10017.
[12] Senoo H, Kamimura Y, Kimura R, et al. Phosphorylated Rho-GDP directly activates mTORC2 kinase towards AKT through dimerization with Ras-GTP to regulate cell migration [J]. Nat Cell Biol, 2019, 21(7):867-878.
[13] Bozza WP, Zhang Y, Hallett K, et al. Rho GDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression [J]. Oncotarget, 2015, 6(32):32723-32736.
[14] Wang C, Wang X, Su Z, et al. MiR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1 [J]. Oncotarget, 2015, 6(34):36231-36244.
[15] Pathak B, Zhao S, Manoharan M, et al. Dualtargeting by CRISPR/Cas9 leads to efficient point mutagenesis but only rare targeted deletions in the rice genome [J]. 3 Biotech, 2019, 9(4):158-169.
[16] Mehta D, Stürchler A, Anjanappa RB, et al. Linking CRISPR-Cas9 interference in cassava to the evolution of editing-resistant geminiviruses [J]. Genome Biol, 2019, 20(1):80-89.
[17] He X, Wang Y, Yang F, et al. Boosting activity of high-fidelity CRISPR/Cas9 variants using a tRNAGln-processing system in human cells [J]. J Biol Chem, 2019, 294(23):9308-9315.
[18] Qi YX, Qu MJ, Long DK, et al. Rho-GDP dissociation inhibitor alpha downregulated by low shear stress promotes vascular smooth muscle cell migration and apoptosis: a proteomic analysis [J]. Cardiovasc Res, 2008, 80(1):114-122.
|